BIOLARGO, INC.
Data quality: 83%
BLGO
OTC
Manufacturing
Chemicals
$0.15
▼
$0.01
(-6.25%)
Mkt Cap: 48.04 M
Price
$0.15
Mkt Cap
48.04 M
Day Range
$0.15 — $0.15
52-Week Range
$0.14 — $0.26
Volume
20,700
Open $0.15
50D / 200D Avg
$0.17
12.28% below
50D / 200D Avg
$0.18
17.36% below
Quick Summary
Key Takeaways
Negative free cash flow of -8.30 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-198.10%
Below sector avg (-53.41%)
ROIC-166.48%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio1.67
Interest Coverage-27.51
Valuation
PE (TTM)
-3.16
Below sector avg (-1.48)
P/B Ratio7.30
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (1364 peers)
Peer Comparison
vs Manufacturing sector median (1364 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -3.2 | -1.5 |
| P/B | 7.3 | 1.6 |
| ROE % | -198.1 | -53.4 |
| Net Margin % | — | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -15.19 M |
| ROE | -198.10% | ROA | -140.45% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -8.30 M |
| ROIC | -166.48% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.67 |
| Interest Coverage | -27.51 | Asset Turnover | N/A |
| Working Capital | 2.32 M | Tangible Book Value | 6.58 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -3.16 | Forward P/E | N/A |
| P/B Ratio | 7.30 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -17.27% | ||
| Market Cap | 48.04 M | Enterprise Value | 43.49 M |
| Per Share | |||
| EPS (Diluted TTM) | N/A | Revenue / Share | N/A |
| FCF / Share | -0.03 | OCF / Share | -0.03 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 54.63% |
| SBC-Adj. FCF | -10.49 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | 12.23 M | — | — |
| Net Income | -15.19 M | -4.35 M | -4.65 M | -5.13 M | -6.89 M |
| EPS (Diluted) | — | — | — | — | — |
| Gross Profit | 3.41 M | 7.85 M | 6.15 M | 2.86 M | 1.10 M |
| Operating Income | -14.86 M | -4.33 M | -4.58 M | -5.39 M | -6.44 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 2.59 M | 2.88 M | 2.28 M | 1.32 M | 1.37 M |
| SG&A Expenses | 11.77 M | 9.30 M | 8.06 M | 6.73 M | 6.17 M |
| D&A | — | — | 103,000.0 | 45,000.0 | 20,000.0 |
| Interest Expense | 540,000.0 | 66,000.0 | 91,000.0 | 53,000.0 | 234,000.0 |
| Income Tax | — | 0.0 | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 8.31 M | 10.51 M | 8.21 M | 4.86 M | 3.02 M |
| Total Liabilities | 6.79 M | 4.46 M | 4.00 M | 2.85 M | 2.09 M |
| Shareholders' Equity | 4.04 M | 8.85 M | 6.84 M | 4.88 M | 4.65 M |
| Total Debt | 2.08 M | 1.08 M | 289,000.0 | 237,000.0 | 180,000.0 |
| Cash & Equivalents | 3.88 M | 3.55 M | 3.54 M | 1.85 M | 962,000.0 |
| Current Assets | 5.11 M | 7.14 M | 6.36 M | 3.15 M | 1.80 M |
| Current Liabilities | 5.06 M | 2.65 M | 2.71 M | 1.58 M | 1.37 M |
{"event":"ticker_viewed","properties":{"ticker":"BLGO","listing_kind":"stock","pathname":"/stocks/blgo","exchange":"OTC","country":"US"}}